Clinical trials in Wolfsburg – page 3

34 clinical trials in Wolfsburg, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Wolfsburg at a glance

clinical trials

Research sites1

Quick filters

34 trials in Wolfsburg

Open in trial search

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Contact Research Centre

Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Heidelberg University

Contact Research Centre

Study comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Heidelberg University

Contact Research Centre

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bemarituzumab
Sponsor:Amgen Inc.

Contact Research Centre

Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Tesaro Inc.

Contact Research Centre

Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Technische Universitaet Dresden

Contact Research Centre

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Blinatumomab
Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Contact Research Centre

Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Lidocaine Hydrochloride Monohydrate
Sponsor:Orexa B.V.

Contact Research Centre

Study of Pembrolizumab, Trastuzumab, and Drug Combination for Patients with HER2-Positive, Localized Esophagogastric Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Disodium Folinate
Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Contact Research Centre

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Crisantaspase
Sponsor:Universita Degli Studi Di Milano Bicocca

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wolfsburg

What the registry says about research in the country

01 Oncology Research

Comprehensive studies focusing on gastrointestinal cancers, including innovative treatments for esophageal and gastric adenocarcinomas. Multiple trials evaluating combination therapies with immunotherapy agents.

Advanced Gastric Cancer
Ovarian Cancer
Rectal Cancer

Investigating novel treatment approaches including targeted therapies and immunotherapy combinations.

02 Hematologic Malignancies

Groundbreaking research in acute lymphoblastic leukemia treatments, particularly focusing on pediatric and adolescent patients. Studies include novel therapeutic combinations and targeted approaches.

Lymphoma Treatment
Philadelphia Chromosome-positive ALL
Diffuse Large B-Cell Lymphoma

Emphasis on personalized treatment strategies and improved outcomes for blood cancers.

03 Preventive Medicine

Studies examining preventive approaches for various conditions, including meningococcal infection prevention through vaccination and dermatological interventions.

Vaccine Development
Atopic Dermatitis Prevention
Post-Surgical Care

Focus on early intervention and disease prevention strategies in diverse patient populations.

Back to Germany All countries

Clinical trials in Wolfsburg – page 3

34 trials in Wolfsburg

Adenocarcinoma gastric+1

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Rectal cancer

Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

Oesophageal adenocarcinoma

Study comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate

Gastric cancer

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Ovarian cancer stage IV+1

Study of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer

Colon cancer stage II+1

Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

Acute lymphocytic leukaemia

Study on Improving Treatment for Children and Adolescents with Acute Lymphoblastic Leukemia Using Bortezomib, Blinatumomab, and a Drug Combination

Laparotomy

Study on Oral Lidocaine for Reducing Gastrointestinal Issues in Patients After Abdominal Surgery

Gastrooesophageal cancer+1

Study of Pembrolizumab, Trastuzumab, and Drug Combination for Patients with HER2-Positive, Localized Esophagogastric Cancer

Acute lymphocytic leukaemia

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Filter the trials

Other cities in Germany

Clinical research in Wolfsburg

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Wolfsburg – page 3

34 trials in Wolfsburg

Adenocarcinoma gastric+1

Ovarian cancer stage IV+1

Colon cancer stage II+1

Gastrooesophageal cancer+1

Other cities in Germany

Related

Clinical research in Wolfsburg

Prefer not to search? Our Concierge searches the trials for you.